Posted On: 03/13/2016 2:17:16 PM
Post# of 223
EPS for BioPharmX Corp (BPMX) Projected to Increase
Analysts await BioPharmX Corp (NYSEMKT:BPMX) to reports earnings on March, 14. After $-0.18 actual EPS reported by BioPharmX Corp for the previous quarter, Wall Street now forecasts -11.11 % EPS growth. The stock decreased 0.67% or $0.01 on March 11, hitting $1.48. About 1,505 shares traded hands. BioPharmX Corp (NYSEMKT:BPMX) has declined 24.62% since August 6, 2015 and is downtrending. It has underperformed by 21.67% the S&P500.
Read more: http://www.octafinance.com/eps-for-biopharmx-...z42oASvIMn
Analysts await BioPharmX Corp (NYSEMKT:BPMX) to reports earnings on March, 14. After $-0.18 actual EPS reported by BioPharmX Corp for the previous quarter, Wall Street now forecasts -11.11 % EPS growth. The stock decreased 0.67% or $0.01 on March 11, hitting $1.48. About 1,505 shares traded hands. BioPharmX Corp (NYSEMKT:BPMX) has declined 24.62% since August 6, 2015 and is downtrending. It has underperformed by 21.67% the S&P500.
Read more: http://www.octafinance.com/eps-for-biopharmx-...z42oASvIMn
(0)
(0)Scroll down for more posts ▼
